CYTOTIL
Dead / Abandoned — Abandoned — failure to respond (as of 26 Aug 2025)
What this means for you
This application is over — abandoned 31 Jul 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98806447
- Mark type
- Stylized text
- Filed
- 17 Oct 2024
- Abandoned
- 31 Jul 2025
- Attorney of record
- Olivia Maria Baratta
Goods and services
- Class 001 — Chemicals: Cells for scientific, laboratory or medical research
- Class 005 — Pharmaceuticals: Cells for medical or clinical use; Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, and immunotherapy for the prevention and treatment of cancer, cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders; Biological preparations for the treatment of cancer
Owner
- Obsidian Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 26 Aug 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 26 Aug 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 30 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Apr 2025 — NON-FINAL ACTION E-MAILED
- 30 Apr 2025 — NON-FINAL ACTION WRITTEN
- 21 Apr 2025 — ASSIGNED TO EXAMINER
- 18 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Oct 2024 — NEW APPLICATION ENTERED